[Form 4] MiMedx Group, Inc Insider Trading Activity

Rhea-AI Filing Summary

MiMedx Group Chief Commercial Officer Kimberly Maersk-Moller reported a Form 4 filing on June 28, 2025, disclosing a transaction dated June 24, 2025. The insider disposed of 12,034 shares of Common Stock at a price of $5.96 per share through a tax withholding transaction (Code F).

Key Transaction Details:

• The shares were withheld for payment of tax liability upon vesting of restricted stock units
• Following the transaction, Maersk-Moller directly owns 295,282 shares of Common Stock
• The transaction was executed under a Form 4 filing obligation pursuant to Section 16(a) of the Securities Exchange Act

This routine tax-related share withholding suggests the vesting of previously awarded restricted stock units, rather than an open market sale decision by the insider.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maersk-Moller Kimberly

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2025		F		12,034(1)	D	$5.96	295,282	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for payment of tax liability upon vesting of restricted stock units.

Remarks:

	/s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller	06/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MDXG shares were disposed of by Kimberly Maersk-Moller on June 24, 2025?

Kimberly Maersk-Moller, MDXG's Chief Commercial Officer, disposed of 12,034 shares of common stock on June 24, 2025. These shares were withheld for payment of tax liability upon vesting of restricted stock units.

What is the current position of Kimberly Maersk-Moller at MDXG?

Kimberly Maersk-Moller serves as the Chief Commercial Officer of MiMedx Group, Inc. (MDXG), as indicated in the Form 4 filing.

What was the price per share for MDXG's stock transaction on June 24, 2025?

The shares were disposed of at a price of $5.96 per share, as reported in the Form 4 filing.

How many MDXG shares does Kimberly Maersk-Moller own after the June 24, 2025 transaction?

Following the reported transaction, Kimberly Maersk-Moller directly owns 295,282 shares of MDXG common stock.

Why did MDXG's Chief Commercial Officer dispose of shares on June 24, 2025?

The shares were withheld by the company for payment of tax liability upon the vesting of restricted stock units, as explained in footnote 1 of the Form 4 filing. This was not an open market sale.